The 1 analysts offering 12-month price forecasts for BlackRock Health Sciences Trust have a median target of 32.98, with a high estimate of 32.98 and a low estimate of 32.98. The median estimate represents a -31.35% decrease from the last price of 48.04.
The current consensus among 1 polled investment analysts is to Hold stock in BlackRock Health Sciences Trust. This rating has held steady since January, when it was downgraded from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share --
Reporting Date TBD
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.